Apolipoprotein E: far more than a lipid transport protein
- PMID: 11701639
- DOI: 10.1146/annurev.genom.1.1.507
Apolipoprotein E: far more than a lipid transport protein
Abstract
First recognized as a major determinant in lipoprotein metabolism and cardiovascular disease, apolipoprotein (apo) E has emerged as an important molecule in several biological processes not directly related to its lipid transport function, including Alzheimer's disease and cognitive function, immunoregulation, and possibly even infectious diseases. ApoE is a polymorphic protein arising from three alleles at a single gene locus. The three major isoforms, apoE4, apoE3, and apoE2, differ from one another only by single amino acid substitutions, yet these changes have profound functional consequences at both the cellular and molecular levels. ApoE3 seems to be the normal isoform in all known functions, while apoE4 and apoE2 can each be dysfunctional. Isoform (allele)-specific effects include the association of apoE2 with the genetic disorder type III hyperlipoproteinemia and with both increased and decreased risk for atherosclerosis and the association of apoE4 with increased risk for both atherosclerosis and Alzheimer's disease, impaired cognitive function, and reduced neurite outgrowth; isoform-specific differences in cellular signaling events may also exist. Functional differences in the apoE isoforms that affect (or did affect) survival before the reproductive years probably account, at least in part, for the allele frequencies of the present day.
Similar articles
-
Apolipoprotein E isoforms and lipoprotein metabolism.IUBMB Life. 2014 Sep;66(9):616-23. doi: 10.1002/iub.1314. IUBMB Life. 2014. PMID: 25328986 Review.
-
Mechanisms linking apolipoprotein E isoforms with cardiovascular and neurological diseases.Curr Opin Lipidol. 2010 Aug;21(4):337-45. doi: 10.1097/MOL.0b013e32833af368. Curr Opin Lipidol. 2010. PMID: 20531185 Review.
-
Analysis of early effects of human APOE isoforms on Alzheimer's disease and type III hyperlipoproteinemia pathways using knock-in rat models with humanized APP and APOE.Cell Commun Signal. 2024 Sep 27;22(1):458. doi: 10.1186/s12964-024-01832-2. Cell Commun Signal. 2024. PMID: 39334477 Free PMC article.
-
Apolipoprotein E and familial dysbetalipoproteinemia: clinical, biochemical, and genetic aspects.Semin Vasc Med. 2004 Aug;4(3):249-57. doi: 10.1055/s-2004-861492. Semin Vasc Med. 2004. PMID: 15630634 Review.
-
Functional characterization of apolipoprotein E isoforms overexpressed in Escherichia coli.Protein Expr Purif. 1999 Jul;16(2):224-30. doi: 10.1006/prep.1999.1069. Protein Expr Purif. 1999. PMID: 10419818
Cited by
-
Pathological Involvement of Protein Phase Separation and Aggregation in Neurodegenerative Diseases.Int J Mol Sci. 2024 Sep 23;25(18):10187. doi: 10.3390/ijms251810187. Int J Mol Sci. 2024. PMID: 39337671 Free PMC article. Review.
-
Contrasting association pattern of plasma low-density lipoprotein with white matter integrity in APOE4 carriers versus non-carriers.Neurobiol Aging. 2024 Nov;143:41-52. doi: 10.1016/j.neurobiolaging.2024.08.005. Epub 2024 Aug 22. Neurobiol Aging. 2024. PMID: 39213809
-
APOE-NOTCH axis governs elastogenesis during human cardiac valve remodeling.Nat Cardiovasc Res. 2024 Aug;3(8):933-950. doi: 10.1038/s44161-024-00510-3. Epub 2024 Jul 24. Nat Cardiovasc Res. 2024. PMID: 39196035
-
Hyperlipidemia-induced hematopoiesis is repressed by MLKL in endothelial cells of the splenic niche.Nat Cardiovasc Res. 2024 May;3(5):594-611. doi: 10.1038/s44161-024-00470-8. Epub 2024 May 17. Nat Cardiovasc Res. 2024. PMID: 39195940
-
Human apolipoprotein E glycosylation and sialylation: from structure to function.Front Mol Neurosci. 2024 Aug 7;17:1399965. doi: 10.3389/fnmol.2024.1399965. eCollection 2024. Front Mol Neurosci. 2024. PMID: 39169951 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous